Biomedical Engineering Reference
In-Depth Information
Gabizon, A., Goren, D., Ramu, A., and Barenholz, Y., Design, characterization
and anti-tumor activity of Adriamycin-containing phospholipid
vesicles. In: Targeting of Drugs with Synthetic Systems (Gregoriadis,
G., Senior, J. and Poste, G., eds.), NATO ASI Series, Plenum, New York,
pp. 229-238 (1986a).
Gabizon, A., Huang A., Martin, F., and Barenholz. Y., Doxorubicin
encapsulation in polyethylene glycol-coated liposomes: initial clinical
pharmacokinetic studies in solid tumors. In: Stealth Liposomes (Lasic,
D.D., and Martin F., eds), CRC Press, Boca Raton, FL, Chapter 21, pp.
245-255 (1995).
Gabizon, A., Meshorer, A., and Barenholz, Y., Comparative long-term study of
the toxicities of free and liposome-associated doxorubicin in mice after
intravenous administration, J. Natl. Cancer Inst . 77, 459-469 (1986b).
Gabizon, A., and Papahadjoupoulos, D., Liposome formulations with
prolonged circulation time in blood and enhanced uptake by tumors,
Proc. Natl. Acad. Sci. USA , 85 , 6949-6953 (1988).
Gabizon, A., Peretz, T., Sulkes, A., Amselem, S., Ben-Yosef, R., Ben-Baruch,
N., Catane, R., Biran, S., and Barenholz, Y., Systemic administration of
doxorubicin-containing liposomes in cancer patients: phase I study,
Eur. J. Cancer Clin. Oncol. , 25 , 1795-1803 (1989a).
Gabizon, A., Shmeeda, H., and Barenholz, Y., Pharmacokinetics of pegylated
liposomal doxorubicin: review of animal and human studies, Clin.
Pharmacokinet. , 42 , 419-436 (2003).
Gabizon, A.A., Sulkes, A., Peretz, T., Druckmann, S., Goren, D., Amselem,
S., and Barenholz, Y., Liposome-associated doxorubicin: preclinical
pharmacology and exploratory clinical phase. In: Liposomes in
the Therapy of Infectious Diseases and Cancer (Fidler, I.J., and
Lopez-Berestein, G., eds.) A.R.L., New York, pp. 391-402 (1989b).
Garbuzenko, O., Barenholz, Y., and Priev, A., Eff ect of grafted PEG on liposome
size and on compressibility and packing of lipid bilayer, Chem. Phys.
Lipids , 135 , 117-129 (2005).
Goormaghtigh, E., and Ruysschaert, J.M., Anthracycline glycoside membrane
interaction, Biochim. Biophys. Acta , 779, 271-188 (1984).
Gordon, A.N., Fleagle, J.T., Guthrie, D., Parkin, D.E., Gore, M.E., and Lacave, A.J.,
Recurrent epithelial ovarian carcinoma: a randomized phase III study
of pegylated liposomal doxorubicin versus topotecan, J. Clin. Oncol .,
19 (14), 3312-3322 (2001).
Gordon, A.N., Granai, C.O., Rose, P.G., Hainsworth, J., Lopez, A., Weissman, C.,
Rosales, R., Sharpington, T., Phase II study of liposomal doxorubicin
in platinum- and paclitaxel-refractory epithelial ovarian cancer, J. Clin.
Oncol ., 18 (17), 3093-3100 (2000).
 
Search WWH ::




Custom Search